Physician profile
John D Fetzer
NPI 1194712620
$2,504.01
in general payments reported to CMS, 2019-2025
28 companies · $318 in 2025
The $318 reported for 2025 was more than what a typical Foot Surgery provider received nationally (typical 2025 total: $180).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $220 · 2020: $197 · 2021: $663 · 2022: $387 · 2023: $155 · 2024: $563 · 2025: $318.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,037.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,036.63 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Melinta Therapeutics, LLC | $344.93 | 2019-2022 | |
| Organogenesis INC. | $307.15 | 2020-2025 | Novachor |
| Paratek Pharmaceuticals, INC. | $283.78 | 2021-2024 | Nuzyra |
| Convatec INC. | $209.83 | 2022-2024 | |
| Stryker Corporation | $197.91 | 2019-2024 | Ortholoc 3di, Prostep Mica, N/A |
| Horizon Therapeutics Plc | $164.22 | 2019-2022 | |
| Smith+Nephew, INC. | $133.09 | 2019-2025 | Renasys Go V2 Home |
| Bioventus LLC | $131.22 | 2025 | Exogen Ultrasound Bone Healing System |
| Amniox Medical, INC. | $124.94 | 2020 | |
| Averitas Pharma INC. | $90.32 | 2023-2024 | Qutenza |
| Amgen INC. | $80.40 | 2024-2025 | Krystexxa |
| Orthofix Medical, INC. | $43.50 | 2023-2025 | Physio-Stim |
| Rock Medical Orthopedics, INC. | $40.33 | 2019 | |
| Ani Pharmaceuticals, INC. | $40.27 | 2023-2025 | Purified Cortrophin Gel |
| Tactile Systems Technology INC | $35.82 | 2024 | Entre Plus, Flexitouch Plus |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mimedx Group, INC. | $34.34 | 2024-2025 | |
| Zyla Life Sciences, INC. | $33.54 | 2019 | |
| Integra Lifesciences Corporation | $29.09 | 2021 | |
| Depuy Synthes Sales INC. | $25.90 | 2025 | Na, Hammerlock |
| Kerecis Limited | $23.93 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose |
| Medtronic, INC. | $23.71 | 2025 | Inceptiv |
| Nabriva Therapeutics, Plc | $20.01 | 2022 | |
| Allergan, INC. | $19.98 | 2020 | |
| Triad Life Sciences INC. | $14.76 | 2022 | |
| Highridge Medical LLC | $14.25 | 2024 | Biomet Orthopak Non-Invasive Bone Growth Stimulator System, Biomet Ebi Bone Healing System |
| Nevro Corp. | $14.00 | 2024 | Senza |
| Abbvie INC. | $12.56 | 2021 | |
| Paragon 28, INC. | $10.23 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Fetzer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.